155 related articles for article (PubMed ID: 828517)
1. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.
Jordan VC
Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517
[TBL] [Abstract][Full Text] [Related]
2. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
3. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
5. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptors in androgen-induced breast tumor regression.
Zava DT; McGuire WL
Cancer Res; 1977 Jun; 37(6):1608-10. PubMed ID: 192456
[TBL] [Abstract][Full Text] [Related]
7. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of tamoxifen in laboratory animals.
Jordan VC; Allen KE; Dix CJ
Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
[TBL] [Abstract][Full Text] [Related]
9. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
Jordan VC
J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
[TBL] [Abstract][Full Text] [Related]
10. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
Ip MM; Milholland RJ; Rosen F
Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
[TBL] [Abstract][Full Text] [Related]
11. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
[TBL] [Abstract][Full Text] [Related]
12. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
Janssens JP; Billiet G; Bonte J; De Loecker W
Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
Robinson SP; Jordan VC
Cancer Res; 1987 Oct; 47(20):5386-90. PubMed ID: 3115568
[TBL] [Abstract][Full Text] [Related]
14. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas.
Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C
Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824
[TBL] [Abstract][Full Text] [Related]
16. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
17. Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
Boylan ES; Wittliff JL
Cancer Res; 1975 Mar; 35(3):506-11. PubMed ID: 163681
[TBL] [Abstract][Full Text] [Related]
18. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
[TBL] [Abstract][Full Text] [Related]
19. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
Rorke EA; Katzenellenbogen BS
Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
